Signaling Pathways - CK1 - endothelin receptor - DOT1L - P-glycoprotein (P-gp)
清除全部
- B5082 FR 139317Target: endothelin receptorSummary: 选择性ETA内皮素受体拮抗剂
- B1581 EPZ004777 HClTarget: DOT1LSummary: DOT1L抑制剂
- A8549 LY335979 (Zosuquidar 3HCL)1 Citation中文名: 唑喹达三盐酸盐Target: P-glycoprotein (P-gp)Summary: Pgb(P糖蛋白)抑制剂
- A3956 ZosuquidarTarget: P-glycoprotein (P-gp)|Cytochrome P450 (CYP450)Summary: MDR调节剂
- A3859 Tariquidar methanesulfonate, hydrate中文名: 他立喹达二甲磺酸盐六水合物Target: P-glycoprotein (P-gp)Summary: P-糖蛋白抑制剂
- A3719 PF-670462Target: CK1Summary: CK1 ε/δ抑制剂
- A3384 Elacridar中文名: 依克立达Target: P-glycoprotein (P-gp)Summary: BCRP抑制剂
- A3342 D44761 CitationTarget: CK1Summary: CK1/ALK5抑制剂
- A8208 Tariquidar2 Citation中文名: 他立喹达Target: P-glycoprotein (P-gp)Summary: P-糖蛋白抑制剂
- A4170 EPZ004777Target: DOT1LSummary: DOT1L抑制剂